Grant: Undergraduate Student Research Awards (USRA)
University of Ottawa
$6,000.00
Validating lipidomic signatures of vascular dementia and cerebral amyloid angiopathy by advanced mas
FY 2026-27
Summary
Vascular cognitive impairment (VCI) arises primarily as a result of cerebral small vessel disease cSVD accounts for approximately 30% of all cases of dementia. cSVD is defined in magnetic resonance imaging (MRI) studies by small subcortical infarcts, lacunes, and white matter hyperintensities (WMHs). Moreover, cSVD patients have frequent, small cerebral infarcts that collectively accelerate cognitive decline. A second vascular cause of dementia is cerebral amyloid angiopathy (CAA), the deposition of amyloid ß within the walls of cerebral vasculature, associated with an increased mortality, and, like VCI, an increased risk of ischemic stroke and intracerebral hemorrhage. In this project, we will establish whether the lipidomic signatures in circulation of persons with VCI and CAA are distinct and validate the onset of this signature in the TgCRND8 mouse model of vascular amyloidosis. Lipids will be profiled by LC-ESI-MS/MS, Reversed phase LC-ESI-DMS-MS/MS, and HILIC-LC-ESI-MS/MS in both humans and the TgCRND8 CAA mouse model and signatures associated with the extent of white matter hyperintensities (MRI), vascular amyloidosis (PET and in situ investigation), MoCA (cognitive testing), MWM (behavioural cognitive testing). Thie identities of each lipid changing in circulation in VCI and CAA patients and TgCRND mice compared to healthy controls will e established by independent data acquisition-enhanced product ion scan-electrospray ionization tandem mass spectrometry (IDA-EPI-ESI-MS/MS). Ms Dazogbo will be responsible for quantifying, analysing, and structurally identifying these lipids through analysis of the IDA-EPI-ESI-MS/MS spectra and establishing the confidence level of each lipid identification.
Department
Program
Undergraduate Student Research Awards (USRA)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
571598
Name
Dazogbo Esther
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Validating lipidomic signatures of vascular dementia and cerebral amyloid angiopathy by advanced mas
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Ottawa
Cihramount2
$6,000
Cihrequipment2
$0
Programname2
Undergraduate Student Research Awards (USRA)
Keyworddelim
Cerebral Small Vessel Disease; Dementia; Vascular Cognitive Impairment
Abstract
Vascular cognitive impairment (VCI) arises primarily as a result of cerebral small vessel disease cSVD accounts for approximately 30% of all cases of dementia. cSVD is defined in magnetic resonance imaging (MRI) studies by small subcortical infarcts, lacunes, and white matter hyperintensities (WMHs). Moreover, cSVD patients have frequent, small cerebral infarcts that collectively accelerate cognitive decline. A second vascular cause of dementia is cerebral amyloid angiopathy (CAA), the deposition of amyloid ß within the walls of cerebral vasculature, associated with an increased mortality, and, like VCI, an increased risk of ischemic stroke and intracerebral hemorrhage. In this project, we will establish whether the lipidomic signatures in circulation of persons with VCI and CAA are distinct and validate the onset of this signature in the TgCRND8 mouse model of vascular amyloidosis. Lipids will be profiled by LC-ESI-MS/MS, Reversed phase LC-ESI-DMS-MS/MS, and HILIC-LC-ESI-MS/MS in both humans and the TgCRND8 CAA mouse model and signatures associated with the extent of white matter hyperintensities (MRI), vascular amyloidosis (PET and in situ investigation), MoCA (cognitive testing), MWM (behavioural cognitive testing). Thie identities of each lipid changing in circulation in VCI and CAA patients and TgCRND mice compared to healthy controls will e established by independent data acquisition-enhanced product ion scan-electrospray ionization tandem mass spectrometry (IDA-EPI-ESI-MS/MS). Ms Dazogbo will be responsible for quantifying, analysing, and structurally identifying these lipids through analysis of the IDA-EPI-ESI-MS/MS spectra and establishing the confidence level of each lipid identification.
Competitiondate
202605
Approvedterm2
0 yr 4 mths
Pinamesdelim
Dazogbo, Esther
Approvedterm
0 an 4 mois
Cihrcontribution2
~ $6,000~ $0~